Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $379.24 | 12 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $145.33 | 8 | $0 (2019) |
| Allergan, Inc. | $88.01 | 1 | $0 (2020) |
| UCB, Inc. | $84.10 | 1 | $0 (2022) |
| Celgene Corporation | $31.86 | 1 | $0 (2019) |
| Medtronic Vascular, Inc. | $29.94 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $84.10 | 1 | UCB, Inc. ($84.10) |
| 2020 | $88.01 | 1 | Allergan, Inc. ($88.01) |
| 2019 | $126.67 | 6 | Novartis Pharmaceuticals Corporation ($94.81) |
| 2018 | $50.52 | 3 | Novartis Pharmaceuticals Corporation ($50.52) |
| 2017 | $29.94 | 1 | Medtronic Vascular, Inc. ($29.94) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/15/2022 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $84.10 | General |
| Category: Neurology | ||||||
| 03/04/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $88.01 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2019 | Celgene Corporation | Ozanimod (Drug) | Food and Beverage | In-kind items and services | $31.86 | General |
| 09/05/2019 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: DERMATOLOGY | ||||||
| 07/09/2019 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: DERMATOLOGY | ||||||
| 05/02/2019 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: DERMATOLOGY | ||||||
| 02/26/2019 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: DERMATOLOGY | ||||||
| 01/15/2019 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: DERMATOLOGY | ||||||
| 11/13/2018 | Novartis Pharmaceuticals Corporation | XOLAIR (Biological) | Food and Beverage | In-kind items and services | $11.16 | General |
| Category: RESPIRATORY | ||||||
| 07/27/2018 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: DERMATOLOGY | ||||||
| 07/23/2018 | Novartis Pharmaceuticals Corporation | XOLAIR (Biological) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: RESPIRATORY | ||||||
| 07/12/2017 | Medtronic Vascular, Inc. | Reveal LINQ (Device) | Food and Beverage | In-kind items and services | $29.94 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 269 | 288 | $102,061 | $34,255 |
| 2022 | 6 | 248 | 314 | $131,120 | $47,060 |
| 2021 | 9 | 385 | 489 | $203,370 | $74,579 |
| 2020 | 5 | 297 | 405 | $175,300 | $65,342 |
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 110 | 110 | $44,110 | $14,483 | 32.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 63 | 82 | $40,754 | $13,166 | 32.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 18 | 18 | $4,878 | $1,831 | 37.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 19 | 19 | $3,914 | $1,710 | 43.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 13 | 13 | $4,552 | $1,572 | 34.5% |
| 99447 | Telephone or internet assessment with verbal and written report by consulting physician, 11-20 minutes | Facility | 2023 | 31 | 31 | $2,263 | $859.01 | 38.0% |
| 99448 | Telephone or internet assessment with verbal and written report by consulting physician, 21-30 minutes | Facility | 2023 | 15 | 15 | $1,590 | $633.15 | 39.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 102 | 164 | $81,508 | $27,763 | 34.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 77 | 78 | $31,278 | $11,755 | 37.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 26 | 26 | $9,074 | $3,762 | 41.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 20 | 23 | $4,738 | $1,843 | 38.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 12 | 12 | $2,916 | $1,378 | 47.2% |
| 99449 | Telephone or internet assessment with verbal and written report by consulting physician, more than 30 minutes | Facility | 2022 | 11 | 11 | $1,606 | $558.55 | 34.8% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 161 | 259 | $128,723 | $44,994 | 35.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 111 | 114 | $45,714 | $17,941 | 39.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 27 | 27 | $9,423 | $3,843 | 40.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 21 | 21 | $5,691 | $2,250 | 39.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 14 | 15 | $3,645 | $1,708 | 46.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 13 | 15 | $3,090 | $1,212 | 39.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 12 | 12 | $3,324 | $1,136 | 34.2% |
| 99449 | Telephone or internet assessment and management service provided by consultative physician, 31 minutes or more of medical consultative discussion and review | Facility | 2021 | 14 | 14 | $2,044 | $812.98 | 39.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 12 | 12 | $1,716 | $684.12 | 39.9% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 126 | 223 | $110,831 | $39,252 | 35.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 113 | 117 | $46,917 | $19,162 | 40.8% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 26 | 26 | $9,074 | $3,565 | 39.3% |
About Dr. Robert Sterling, M.D
Dr. Robert Sterling, M.D is a Clinical Neurophysiology healthcare provider based in York, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1235169269.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Sterling, M.D has received a total of $379.24 in payments from pharmaceutical and medical device companies, with $84.10 received in 2022. These payments were reported across 12 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($379.24).
As a Medicare-enrolled provider, Sterling has provided services to 1,199 Medicare beneficiaries, totaling 1,496 services with total Medicare billing of $221,237. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Practice Information
- Specialty Clinical Neurophysiology
- Other Specialties Neurology
- Location York, PA
- Active Since 07/04/2006
- Last Updated 03/08/2018
- Taxonomy Code 2084N0600X
- Entity Type Individual
- NPI Number 1235169269
Products in Payments
- COSENTYX (Biological) $118.99
- UBRELVY (Drug) $88.01
- Briviact (Drug) $84.10
- Ozanimod (Drug) $31.86
- Reveal LINQ (Device) $29.94
- XOLAIR (Biological) $26.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.